Staphylococcus aureus Antibiotic Susceptibilities in Infections in an Outpatient Dermatology Office on O'ahu
- PMID: 31049265
- PMCID: PMC6495025
Staphylococcus aureus Antibiotic Susceptibilities in Infections in an Outpatient Dermatology Office on O'ahu
Abstract
Staphylococcus aureus is a pathogen that causes skin and soft tissue infections (SSTIs) in dermatology patients. There is an increasing rate of methicillin-resistant S aureus (MRSA) reported in the dermatology literature since 1987. This report profiles the antibiotic susceptibilities of methicillin-sensitive S aureus (MSSA) and MRSA in an outpatient office in Hawai'i. This is a retrospective study done by chart review from 2012 to 2014. Demographics, anatomical site of infection, clinical diagnoses and antimicrobial susceptibility patterns were analyzed and compared. Of the 66 samples, 57% were males and 43% were females. S aureus was more commonly found in impetigo, folliculitis, furuncles and secondarily infected psoriasis and more commonly located on the extremities. MSSA accounted for 73% (48) of the cases and MRSA accounted for 27% (18) of the cases. The antibiotics most effective against all S aureus cultures for outpatients were linezolid (100%), trimethoprim sulfamethoxazole (95%) and tetracyclines (94%). Linezolid (100%), trimethoprim sulfamethoxazole (100%) were most effective against MRSA isolates. Our S aureus and MRSA antimicrobial susceptibility results are similar to the local Hawai'i outpatient antibiogram collected from a large private laboratory in Hawai'i in 2014 and the current Infectious Disease Society of America guidelines. This study may be helpful in guiding empiric treatment of SSTIs suspected to be caused by S aureus.
Keywords: Hawai‘i; Staphylococcus aureus; antimicrobial susceptibility; dermatology; methicillin-resistant S aureus; methicillin-sensitive S aureus; outpatient.
Conflict of interest statement
None of the authors identify any conflicts of interest.
Figures
Similar articles
-
Trends and antibiotic susceptibility patterns of methicillin-resistant and methicillin-sensitive Staphylococcus aureus in an outpatient dermatology facility.JAMA Dermatol. 2013 Apr;149(4):427-32. doi: 10.1001/jamadermatol.2013.2424. JAMA Dermatol. 2013. PMID: 23325388
-
Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.BMC Infect Dis. 2017 Nov 29;17(1):737. doi: 10.1186/s12879-017-2844-4. BMC Infect Dis. 2017. PMID: 29187146 Free PMC article.
-
Prevalence and clinical characteristics of methicillin-resistant Staphylococcus aureus infections among dermatology inpatients: A 7-year retrospective study at a tertiary care center in southwest China.Front Public Health. 2023 Mar 14;11:1124930. doi: 10.3389/fpubh.2023.1124930. eCollection 2023. Front Public Health. 2023. PMID: 36998271 Free PMC article.
-
Antibiotic Resistance in the Treatment of Staphylococcus aureus Keratitis: a 20-Year Review.Cornea. 2015 Jun;34(6):698-703. doi: 10.1097/ICO.0000000000000431. Cornea. 2015. PMID: 25811722 Free PMC article. Review.
-
Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children.Curr Opin Infect Dis. 2003 Jun;16(3):265-9. doi: 10.1097/00001432-200306000-00014. Curr Opin Infect Dis. 2003. PMID: 12821819 Review.
Cited by
-
Status of Biofilm-Forming Genes among Jordanian Nasal Carriers of Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureus.Iran Biomed J. 2020 Nov;24(6):386-98. doi: 10.29252/ibj.24.6.381. Epub 2020 Jul 8. Iran Biomed J. 2020. PMID: 32660224 Free PMC article.
-
Silver Nanoparticles Functionalized with Polymeric Substances to Reduce the Growth of Planktonic and Biofilm Opportunistic Pathogens.Int J Mol Sci. 2025 Apr 22;26(9):3930. doi: 10.3390/ijms26093930. Int J Mol Sci. 2025. PMID: 40362173 Free PMC article.
References
-
- Centers for Disease Control and Prevention Community associated MRSA and Health Care associated MRSA information for clinicians, author. [10 March 2018]. Available at http://www.cdc.gov/mrsa.
-
- McBride ME, Schaefer D, Rudolph AH, Aldama S, Wolf JE., Jr. Evaluation of antibacterial sensitivity testing methods for methicillin-resistant Staphylococcus aureus in a dermatology outpatient population. South Med J. 1989;82(2):165–168. - PubMed
-
- Price MF, McBride ME, Wolf JE., Jr. Prevalence of methicillin-resistant Staphylococcus aureus in a dermatology outpatient population. South Med J. 1998 Apr;91(4):369–371. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical